Seegene Usa, Inc.
Irvine, CA Sales
- UEI
- YDDKWNE9JAY7
- CAGE
- 7NPS3
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 141 Innovation Dr #200, Irvine, CA 92617, USA
- Website
- seegene.com
- Founded
- 2000
- Employees
- 251-1K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $121,950 |
| FY2025 | $0 |
| FY2024 | $57,490 |
| FY2023 | $85,500 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $121,950 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| EO 14398: novaplex system | CDC Pittsburgh | $121,950 | |
| Novaplex HPV28 detection kit purchase | CDC Pittsburgh | $57,490 | |
| HPV detection RUO assay | CDC Pittsburgh | $85,500 | |
| Seegene novaplex | CDC Pittsburgh | $72,000 | |
| Lab supplies - reagents for HPV test kits | CDC Pittsburgh | $65,375 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Invivoscribe, Inc. | San Diego, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Beacon Scientific Inc. | San Diego, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Tetracore, Inc. | Rockville, MD | 334519 Other Measuring and Controlling Device Manufacturing |
| Quality Biological Inc. | Gaithersburg, MD | 325414 Biological Product (except Diagnostic) Manufacturing |
| Takara Bio Usa, Inc. | San Jose, CA | 325414 Biological Product (except Diagnostic) Manufacturing |
About the company
Seegene USA Inc., a foreign-owned small disadvantaged business headquartered in Irvine, California, supplies molecular diagnostic reagents and HPV detection kits to the federal government as a prime contractor on firm-fixed-price purchase orders. The vendor operates as a for-profit Subchapter S corporation self-certified as a small disadvantaged business; all recent awards use full-and-open competition with no set-aside designation.
Seegene's federal footprint is concentrated in a single customer: the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh location accounts for 100% of the vendor's twelve prime awards and $593 thousand in combined potential value across the measurement period. The vendor supplies NOVAPLEX molecular diagnostic reagents, HPV28 detection kits, and HPV detection assay kits to support CDC's public health mission in human papillomavirus screening and prevention. Representative work includes a $121,950 firm-fixed-price purchase order awarded August 6, 2026, for the NOVAPLEX System (ultimate completion June 14, 2027); a $57,490 purchase order for NOVAPLEX HPV28 detection kits awarded August 8, 2024; and an $85,500 purchase order for HPV detection RUO assay awarded September 21, 2023. The vendor's NAICS concentration splits between drugs and druggist sundries merchant wholesaling (6 awards) and in-vitro diagnostic substance manufacturing (3 awards), with laboratory equipment and supplies (PSC) anchoring nine awards.
Activity has been minimal — one award per year in 2021, 2022, 2023, and 2024, with one award in 2026. One award (combined potential value $122 thousand) reaches ultimate completion within the next twenty-four months. Seegene operates entirely as a prime contractor; it carries no subcontract footprint in the source data.
Quick answers
Is Seegene Usa, Inc. registered in SAM.gov?
Yes. Seegene Usa, Inc.'s SAM.gov registration is active through March 9, 2027.
What is Seegene Usa, Inc.'s CAGE code?
Seegene Usa, Inc.'s CAGE code is 7NPS3, and its Unique Entity ID (UEI) is YDDKWNE9JAY7.
How much has Seegene Usa, Inc. received in federal contracts?
Federal contracts obligated $264,940 to Seegene Usa, Inc. in fiscal years 2023 through 2027.
What is Seegene Usa, Inc.'s most recent federal award?
Seegene Usa, Inc.'s most recent federal contract award is EO 14398: novaplex system (75D30126P21232), from CDC Pittsburgh, on August 6, 2026.
On GovTribe
See Seegene Usa, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors